Fetal tachyarrhythmia - Part II: Treatment

Indian Pacing and Electrophysiology Journal

Volumn 4, Issue 4, 2004, Pages 185-194

  Oudijk, Martijn A ^a   Visser, Gerard H A ^a   Meijboom, Erik J ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Fetal tachyarrhythmia

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; DIGOXIN; FLECAINIDE; SOTALOL;

CLINICAL PROTOCOL; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONSERVATIVE TREATMENT; DISEASE PREDISPOSITION; DISEASE SEVERITY; DIZZINESS; DRUG MECHANISM; DRUG OVERDOSE; DRUG USE; EXTRASYSTOLE; FETUS; FETUS DISEASE; FETUS HYDROPS; FETUS MONITORING; FLUSHING; GESTATIONAL AGE; HEADACHE; HEART BLOCK; HEART DEATH; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HUMAN; MATERNAL WELFARE; MEDICAL DECISION MAKING; NAUSEA; PARESTHESIA; PATHOLOGICAL ANATOMY; PHOTOSENSITIVITY; PLACENTAL TRANSFER; PREDICTION; PRENATAL MORTALITY; RASH; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; TACHYCARDIA; THROMBOCYTOPENIA; TREMOR; TRICUSPID VALVE REGURGITATION; VISUAL DISORDER; VOMITING;

EID: 23144461556     PISSN: 09726292     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Strasburger JF. Fetal arrhythmias. Prog Pediatr Cardiol 2000;11(1):1-17
2. Allan LD, Anderson RH, Sullivan ID, et al. Evaluation of fetal arrhythmias by echocardiography. Br Heart J 1983;50:240-24
3. Kleinman CS, Copel JA, Weinstein EM, et al. Treatment of fetal supraventricular tachyarrhythmias. J Clin Ultrasound 1985;13:265-273
4. Naheed ZJ, Strasburger JF, Deal BJ, Benson DW, Gidding SS. Fetal tachycardia: mechanisms and predictors of hydrops fetalis. J Am Coll Cardiol 1996;27:1736-40
5. Gunteroth WG, Cyr DR, Shields LE, et al. Rate based management of fetal supraventricular tachycardia. J Ultrasound Med 1996;15:453-8
6. Kleinman CS, Nehgme R, Copel JA, et al. Fetal cardiac arrhythmias: diagnosis and therapy. In: Creasy RK, Resnik R, editors. Matern-fetal medicine. Philadelphia (PA): Saunders, 1998:301-318
7. Gest AL, Hansen TN, Moise AA, Hartley CJ. Atrial tachycardia causes hydrops in fetal lambs. Am J Physiol 1990;258:H1159-63
8. Kleinman CS, Copel JA, Weinstein EM, et al. Treatment of fetal supraventricular tachyarrhythmias. J Clin Ultrasound 1985;13:265-273
9. Allan LD. Cardiac ultrasound of the fetus. Arch Dis Childhood 1984;59:603-604
10. Wladimiroff JW, Stewart PA. Treatment of fetal cardiac arrhythmias. Br J Hosp Med 1985: 134-140
11. Jouannic JM, LeBidois J, Fermont L, et al. Prenatal ultrasound may predict fetal response to therapy in non-hydropic fetuses with supraventricular tachycardia. Fetal Diagn Ther 2002;17:120-123
12. Hansmann M, Gembruch U, Bald R, et al. Fetal tachyarrhythmias: transplacental and direct treatment of the fetus. A report of 60 cases. Ultrasound Obstet Gynecol 1991;1:162-170
13. Parilla BV, Strasburger JF, Socol ML. Fetal supraventricular tachycardia complicated by hydrops fetalis: a role for direct fetal intramuscular therapy. Am J Perinatol 1996;13:483-486
14. Kofinas AD, Simon NV, Sagel H, et al. Treatment of fetal supraventricular tachycardia with flecainide acetate after digoxin failure. Am J Obstet Gynecol 1991;165: 630-1
15. Younis JS, Granat M. Insufficient transplacental digoxin transfer in severe hydrops fetalis. Am J Obstet Gynecol 1987;157:1268-1269
16. Simpson LL, Marx GR, D'Alton ME. Supraventricular tachycardia in the fetus: conservative management in the absence of hemodynamic compromise. J Ultrasound Med 1997;16:459-464
17. Gunteroth WG, Cyr DR, Shields LE, et al. Rate-based management of fetal supraventricular tachycardia. J Ultrasound Med 1996;15:453-458
18. Cuneo BF, Strasburger JF. Management strategy for fetal tachycardia. Obstet Gynecol 2000;96:575-81
19. McCormick MC. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 1985;312:82-90
20. Berkowitz GS, Papiernik E. Epidemiology of preterm birth. Epidemiol Rev 1993;15:414-43
21. Lydon-Rochelle M, Holt VL, Easterling, Martin DP. Risk of uterine rupture during labor among women with a prior cesarean delivery. N Engl J Med 2001;345(1):3-8
22. Gielchinsky Y, Rojansky N, Fasouliotis SJ, Ezra Y. Placenta accreta - summary of 10 years: a survey of 310 cases. Placenta 2002;23(2-3):210-4
23. Webb JC, Gilson G, Gordon L. Late second stage rupture of the uterus and bladder with vaginal birth after cesarean section: a case report and review of the literature. Matern Fetal Med 2000;9(6):362-5
24. Hallak M, Neerhof MG, Perry R, Nazir M, Huhta JC. Fetal supraventricular tachycardia and hydrops fetalis: combined intensive, direct, and transplacental therapy. Obstet Gynecol. 1991 Sep;78(3 Pt 2):523-5
25. Kohl T, Tercanli S, Kececioglu D, et al. Direct fetal administration of adenosine for the termination of incessant supraventricular tachycardia. Obstet Gynecol 1995;85:873-874
26. Maxwell DJ, Crawford DC, Curry PVM, et al. Obstetric importance, diagnosis, and management of fetal tachycardias. Br Med J 1988;297:107-110
27. Rogers MC, Willerson JT, Goldblatt A, et al. Serum digoxin concentrations in the human fetus, neonate and infant. N Engl J Med 1972;16:1010-3
28. Chan V, Tse TF, Wong V. Transfer of digoxin across the placenta and into breast milk. Br J Obstet Gynaecol 1978;85:605-9
29. Van Engelen AD, Weijtens O, Brenner JI, et al. Management, outcome and follow-up of fetal tachycardia. J Am Coll Cardiol 1994;24:1371-5
30. Frohn-Mulder IM, Stewart PA, Witsenburg M, et al. The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardia. Pren Diagn 1995;15:1297-1302
31. Simpson JM, Sharland GK. Fetal tachycardias: management and outcome of 127 consecutive cases. Heart 1998;79:576-581
32. Jaeggi E, Fouron JC, Drblik SP. Fetal atrial flutter: diagnosis, clinical features, treatment, and outcome. J Pediatr 1998;132:335-339
33. Krapp M, Kohl T, Simpson JM, Sharland GK, Katalinic A, Gembruch U. Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart. 2003 Aug;89(8):913-7.
34. Oudijk MA, Ruskamp JM, Ambachtsheer EB, et al. Drug treatment of fetal tachycardias. Pediatr Drugs 2002;4(1):49-63
35. Azancot-Benisty A, Jacqz-Aigrain, Guirgis NM, et al. Clinical and pharmacologic study of fetal supraventricular tachyarrhythmias. J Pediatr 1992;121:608-13
36. Wagner X, Jouglard J, Moulin M, et al. Coadministration of flecainide acetate and sotalol during pregnancy: lack of teratogenic effects, passage across the placenta, and excretion in human breast milk. Am Heart J 1990;119:700-702
37. Bourget P, Pons JC, Delouis C, et al. Flecainide distribution, transplacental passage, and accumulation in the amniotic fluid during the third trimester of pregnancy. Ann Pharmacother 1994;28:1031-4
38. Barjot P, Hamel P, Calmelet, et al. Flecainide against fetal supraventricular tachycardia complicated by hydrops fetalis. Acta Obstet Gynecol Scand 1998;77:353-354
39. Allan LD, Chita SK, Sharland GK, Maxwell D, Priestly K. Flecainide in the treatment of fetal tachycardias. Br Heart J 1991;65:46-8
40. Ebenroth ES, Cordes TM, Darragh RK. Second-line treatment of fetal supraventricular tachycardia using flecainide acetate. Pediatr Cardiol 2001;22:483-487
41. Krapp M, Baschat AA, Gembruch U, Geipel A, Germer U. Flecainide in the intrauterine treatment of fetal supraventricular tachycardia. Ultrasound Obstet Gynecol 2002;19:158-164
42. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo, the cardiac arrhythmia suppression trial. N Engl J Med 1991;324: 781-8
43. Gembruch U, Manz M, Bald R, et al. Repeated intravascular treatment with amiodarone in a fetus with refractory supraventricular tachycardia and hydrops fetalis. Am Heart J 1989;118:1335-1338
44. Mangione R, Guyon F, Vergnaud A, et al. Successful treatment of refractory supraventricular tachycardia by repeat intravascular injection of amiodarone with long term follow-up. Prenat Diagn 2000;20:449-452
45. Hijazi ZM, Rosenfeld LE, Copel JA, et al. Amiodarone therapy of intractable atrial flutter in a premature hydropic neonate. Pediatr Cardiol 1992;13:227-229
46. Personal communication with Strasburger JF.
47. Strasburger JF, Cuneo BF, Michon MM, Gotteiner NL, Deal BJ, McGregor SN, Oudijk MA, Meijboom EJ, Feinkind L, Hussey M, Parilla BV. Amiodarone therapy for drug-refractory fetal tachycardia. Circulation. 2004 Jan 27;109(3):375-9.
48. Oudijk MA, Ruskamp JM, Ververs FF, Ambachtsheer EB, Stoutenbeek P, Visser GH, Meijboom EJ. Treatment of fetal tachycardia with sotalol: transplacental pharmacokinetics and pharmacodynamics. J Am Coll Cardiol. 2003 Aug 20;42(4):765-70.
49. Oudijk MA. Fetal tachycardia, diagnosis and treatment and the fetal QT interval in hypoxia. Thesis Utrecht 2003. ISBN 90-393-3301-7.
50. Oudijk MA, Michon MM, Kleinman CS, Kapusta L, Stoutenbeek P, Visser GH, Meijboom EJ. Sotalol in the treatment of fetal dysrhythmias. Circulation. 2000 Jun 13;101(23):2721-6.